These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 16882888
21. Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T Mutations. Gilda JE, Lai X, Witzmann FA, Gomes AV. Mol Cell Proteomics; 2016 Jun; 15(6):1962-81. PubMed ID: 27022107 [Abstract] [Full Text] [Related]
24. Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice. Eijssen LM, van den Bosch BJ, Vignier N, Lindsey PJ, van den Burg CM, Carrier L, Doevendans PA, van der Vusse GJ, Smeets HJ. Genomics; 2008 Jan; 91(1):52-60. PubMed ID: 18060737 [Abstract] [Full Text] [Related]
25. p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in α-tropomyosin Glu180Gly transgenic mice. Passariello CL, Gayanilo M, Kritzer MD, Thakur H, Cozacov Z, Rusconi F, Wieczorek D, Sanders M, Li J, Kapiloff MS. Am J Physiol Heart Circ Physiol; 2013 Oct 01; 305(7):H1010-9. PubMed ID: 23913705 [Abstract] [Full Text] [Related]
26. Abnormal heart rate regulation in murine hearts with familial hypertrophic cardiomyopathy-related cardiac troponin T mutations. Jimenez J, Tardiff JC. Am J Physiol Heart Circ Physiol; 2011 Feb 01; 300(2):H627-35. PubMed ID: 21131475 [Abstract] [Full Text] [Related]
29. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase. Sirenko SG, Potter JD, Knollmann BC. J Physiol; 2006 Aug 15; 575(Pt 1):201-13. PubMed ID: 16777946 [Abstract] [Full Text] [Related]
30. Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene. Gomes AV, Potter JD. Mol Cell Biochem; 2004 Aug 15; 263(1-2):99-114. PubMed ID: 15524171 [Abstract] [Full Text] [Related]
31. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy. Burkart EM, Arteaga GM, Sumandea MP, Prabhakar R, Wieczorek DF, Solaro RJ. J Mol Cell Cardiol; 2003 Oct 15; 35(10):1285-93. PubMed ID: 14519438 [Abstract] [Full Text] [Related]
32. Temporal and morphological impact of pressure overload in transgenic FHC mice. Chen H, Hwang H, McKee LA, Perez JN, Regan JA, Constantopoulos E, Lafleur B, Konhilas JP. Front Physiol; 2013 Oct 15; 4():205. PubMed ID: 23986715 [Abstract] [Full Text] [Related]
36. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy. Evans CC, Pena JR, Phillips RM, Muthuchamy M, Wieczorek DF, Solaro RJ, Wolska BM. Am J Physiol Heart Circ Physiol; 2000 Nov 15; 279(5):H2414-23. PubMed ID: 11045979 [Abstract] [Full Text] [Related]
37. Repairing the myofilaments to heal the heart. Frazier A, Murphy AM. Am J Physiol Heart Circ Physiol; 2007 Aug 15; 293(2):H907-8. PubMed ID: 17416606 [No Abstract] [Full Text] [Related]
38. Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin. Ly S, Lehrer SS. Biochemistry; 2012 Aug 14; 51(32):6413-20. PubMed ID: 22794249 [Abstract] [Full Text] [Related]
39. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy. Semsarian C, Healey MJ, Fatkin D, Giewat M, Duffy C, Seidman CE, Seidman JG. J Mol Cell Cardiol; 2001 Nov 14; 33(11):2055-60. PubMed ID: 11708849 [Abstract] [Full Text] [Related]
40. Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias. Frey N, Franz WM, Gloeckner K, Degenhardt M, Müller M, Müller O, Merz H, Katus HA. Cardiovasc Res; 2000 Aug 14; 47(2):254-64. PubMed ID: 10946062 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]